Making markets for vaccines: ideas to action
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Washington, D.C.
Center for Global Development
c2005
|
Schlagworte: | |
Online-Zugang: | Table of contents Inhaltsverzeichnis |
Beschreibung: | Includes bibliographical references and index |
Beschreibung: | XI, 113 S. |
ISBN: | 1933286024 |
Internformat
MARC
LEADER | 00000nam a2200000zc 4500 | ||
---|---|---|---|
001 | BV020829358 | ||
003 | DE-604 | ||
005 | 20060410 | ||
007 | t | ||
008 | 051013s2005 xxu |||| 00||| eng d | ||
010 | |a 2005011718 | ||
020 | |a 1933286024 |c alk. paper |9 1-9332-8602-4 | ||
035 | |a (OCoLC)65201424 | ||
035 | |a (DE-599)BVBBV020829358 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
044 | |a xxu |c US | ||
049 | |a DE-703 |a DE-83 | ||
050 | 0 | |a HD9675.V333 | |
082 | 0 | |a 338.47615372 |2 22 | |
084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
245 | 1 | 0 | |a Making markets for vaccines |b ideas to action |c the report of the Center for Global Development Advance Market Commitment Working Group. Ruth Levine ... co-chairs |
264 | 1 | |a Washington, D.C. |b Center for Global Development |c c2005 | |
300 | |a XI, 113 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
505 | 8 | |a We need to invest more in vaccines -- Promoting private investment in vaccine development -- A market not a prize -- Design choices -- 3 billion per disease -- Meeting industry requirements -- How sponsors can do it. | |
650 | 4 | |a Industrie pharmaceutique - Pays en voie de développement | |
650 | 4 | |a Médicaments - Pays en voie de développement | |
650 | 4 | |a Vaccins - Industrie - Pays en voie de développement | |
650 | 4 | |a Vaccins - Recherche - Aspect économique - Pays en voie de développement | |
650 | 4 | |a Entwicklungsländer | |
650 | 4 | |a Vaccines industry |z Developing countries | |
650 | 4 | |a Vaccines |x Research |x Economic aspects |z Developing countries | |
650 | 4 | |a Pharmaceutical industry |z Developing countries | |
650 | 4 | |a Pharmaceuticals |z Developing countries | |
650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
651 | 7 | |a Entwicklungsländer |0 (DE-588)4014954-7 |2 gnd |9 rswk-swf | |
655 | 7 | |0 (DE-588)4128022-2 |a Bericht |2 gnd-content | |
689 | 0 | 0 | |a Entwicklungsländer |0 (DE-588)4014954-7 |D g |
689 | 0 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Entwicklungsländer |0 (DE-588)4014954-7 |D g |
689 | 1 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Levine, Ruth |d 1959- |e Sonstige |0 (DE-588)130515051 |4 oth | |
856 | 4 | |u http://www.loc.gov/catdir/toc/ecip0511/2005011718.html |3 Table of contents | |
856 | 4 | 2 | |m LoC Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013834599&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-013834599 |
Datensatz im Suchindex
_version_ | 1804134160365780992 |
---|---|
adam_text | MAKING MARKETS FOR VACCINES / BARDER, OWEN : C2005
TABLE OF CONTENTS / INHALTSVERZEICHNIS
WE NEED TO INVEST MORE IN VACCINES
PROMOTING PRIVATE INVESTMENT IN VACCINE DEVELOPMENT
A MARKET NOT A PRIZE
DESIGN CHOICES
$3 BILLION PER DISEASE
MEETING INDUSTRY REQUIREMENTS
HOW SPONSORS CAN DO IT.
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
any_adam_object | 1 |
author_GND | (DE-588)130515051 |
building | Verbundindex |
bvnumber | BV020829358 |
callnumber-first | H - Social Science |
callnumber-label | HD9675 |
callnumber-raw | HD9675.V333 |
callnumber-search | HD9675.V333 |
callnumber-sort | HD 49675 V333 |
callnumber-subject | HD - Industries, Land Use, Labor |
classification_rvk | QR 525 |
contents | We need to invest more in vaccines -- Promoting private investment in vaccine development -- A market not a prize -- Design choices -- 3 billion per disease -- Meeting industry requirements -- How sponsors can do it. |
ctrlnum | (OCoLC)65201424 (DE-599)BVBBV020829358 |
dewey-full | 338.47615372 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 338 - Production |
dewey-raw | 338.47615372 |
dewey-search | 338.47615372 |
dewey-sort | 3338.47615372 |
dewey-tens | 330 - Economics |
discipline | Wirtschaftswissenschaften |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02770nam a2200589zc 4500</leader><controlfield tag="001">BV020829358</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20060410 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">051013s2005 xxu |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2005011718</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1933286024</subfield><subfield code="c">alk. paper</subfield><subfield code="9">1-9332-8602-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)65201424</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV020829358</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-83</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9675.V333</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.47615372</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Making markets for vaccines</subfield><subfield code="b">ideas to action</subfield><subfield code="c">the report of the Center for Global Development Advance Market Commitment Working Group. Ruth Levine ... co-chairs</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">Center for Global Development</subfield><subfield code="c">c2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 113 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">We need to invest more in vaccines -- Promoting private investment in vaccine development -- A market not a prize -- Design choices -- 3 billion per disease -- Meeting industry requirements -- How sponsors can do it.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - Pays en voie de développement</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Pays en voie de développement</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccins - Industrie - Pays en voie de développement</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccins - Recherche - Aspect économique - Pays en voie de développement</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Entwicklungsländer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines industry</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vaccines</subfield><subfield code="x">Research</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceuticals</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4128022-2</subfield><subfield code="a">Bericht</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Levine, Ruth</subfield><subfield code="d">1959-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)130515051</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/toc/ecip0511/2005011718.html</subfield><subfield code="3">Table of contents</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">LoC Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013834599&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-013834599</subfield></datafield></record></collection> |
genre | (DE-588)4128022-2 Bericht gnd-content |
genre_facet | Bericht |
geographic | Entwicklungsländer (DE-588)4014954-7 gnd |
geographic_facet | Entwicklungsländer |
id | DE-604.BV020829358 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T20:20:12Z |
institution | BVB |
isbn | 1933286024 |
language | English |
lccn | 2005011718 |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-013834599 |
oclc_num | 65201424 |
open_access_boolean | |
owner | DE-703 DE-83 |
owner_facet | DE-703 DE-83 |
physical | XI, 113 S. |
publishDate | 2005 |
publishDateSearch | 2005 |
publishDateSort | 2005 |
publisher | Center for Global Development |
record_format | marc |
spelling | Making markets for vaccines ideas to action the report of the Center for Global Development Advance Market Commitment Working Group. Ruth Levine ... co-chairs Washington, D.C. Center for Global Development c2005 XI, 113 S. txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index We need to invest more in vaccines -- Promoting private investment in vaccine development -- A market not a prize -- Design choices -- 3 billion per disease -- Meeting industry requirements -- How sponsors can do it. Industrie pharmaceutique - Pays en voie de développement Médicaments - Pays en voie de développement Vaccins - Industrie - Pays en voie de développement Vaccins - Recherche - Aspect économique - Pays en voie de développement Entwicklungsländer Vaccines industry Developing countries Vaccines Research Economic aspects Developing countries Pharmaceutical industry Developing countries Pharmaceuticals Developing countries Impfstoff (DE-588)4026655-2 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Entwicklungsländer (DE-588)4014954-7 gnd rswk-swf (DE-588)4128022-2 Bericht gnd-content Entwicklungsländer (DE-588)4014954-7 g Pharmazeutische Industrie (DE-588)4045696-1 s DE-604 Impfstoff (DE-588)4026655-2 s Levine, Ruth 1959- Sonstige (DE-588)130515051 oth http://www.loc.gov/catdir/toc/ecip0511/2005011718.html Table of contents LoC Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013834599&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Making markets for vaccines ideas to action We need to invest more in vaccines -- Promoting private investment in vaccine development -- A market not a prize -- Design choices -- 3 billion per disease -- Meeting industry requirements -- How sponsors can do it. Industrie pharmaceutique - Pays en voie de développement Médicaments - Pays en voie de développement Vaccins - Industrie - Pays en voie de développement Vaccins - Recherche - Aspect économique - Pays en voie de développement Entwicklungsländer Vaccines industry Developing countries Vaccines Research Economic aspects Developing countries Pharmaceutical industry Developing countries Pharmaceuticals Developing countries Impfstoff (DE-588)4026655-2 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
subject_GND | (DE-588)4026655-2 (DE-588)4045696-1 (DE-588)4014954-7 (DE-588)4128022-2 |
title | Making markets for vaccines ideas to action |
title_auth | Making markets for vaccines ideas to action |
title_exact_search | Making markets for vaccines ideas to action |
title_full | Making markets for vaccines ideas to action the report of the Center for Global Development Advance Market Commitment Working Group. Ruth Levine ... co-chairs |
title_fullStr | Making markets for vaccines ideas to action the report of the Center for Global Development Advance Market Commitment Working Group. Ruth Levine ... co-chairs |
title_full_unstemmed | Making markets for vaccines ideas to action the report of the Center for Global Development Advance Market Commitment Working Group. Ruth Levine ... co-chairs |
title_short | Making markets for vaccines |
title_sort | making markets for vaccines ideas to action |
title_sub | ideas to action |
topic | Industrie pharmaceutique - Pays en voie de développement Médicaments - Pays en voie de développement Vaccins - Industrie - Pays en voie de développement Vaccins - Recherche - Aspect économique - Pays en voie de développement Entwicklungsländer Vaccines industry Developing countries Vaccines Research Economic aspects Developing countries Pharmaceutical industry Developing countries Pharmaceuticals Developing countries Impfstoff (DE-588)4026655-2 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
topic_facet | Industrie pharmaceutique - Pays en voie de développement Médicaments - Pays en voie de développement Vaccins - Industrie - Pays en voie de développement Vaccins - Recherche - Aspect économique - Pays en voie de développement Entwicklungsländer Vaccines industry Developing countries Vaccines Research Economic aspects Developing countries Pharmaceutical industry Developing countries Pharmaceuticals Developing countries Impfstoff Pharmazeutische Industrie Bericht |
url | http://www.loc.gov/catdir/toc/ecip0511/2005011718.html http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013834599&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT levineruth makingmarketsforvaccinesideastoaction |